PMID- 8653576
OWN - NLM
STAT- MEDLINE
DCOM- 19960801
LR  - 20061115
VI  - Suppl 1
DP  - 1996
TI  - [Thoracic surgery for non-small cell lung cancer. Cost-benefit of its management 
      in specialized intermediate care].
PG  - 46-51
AB  - In 1989, we reorganized acute and rehabilitation cares for patients operated for 
      non small cell lung cancer (NSCLC) in order to decrease costs by setting up a 
      specialised intermediate care unit (SICU). This report deals with the 
      postoperative complications and the total cost of these cares (SICU, acute and 
      rehabilitation cares) as well as their cost/benefit. From 1990 to 1994, we 
      performed 95 thoracotomies, 7 exploratory and 88 with lung resection (24 
      pneumonectomies, 8 bilobectomies, 48 lobectomies and 8 segmentectomies or wedge 
      resections). The postoperative staging was I in 52, II in 17, III a in 15, S III 
      b in 2, IV in 2. Patients 30-days postoperative mortality was 2/95 (2.1%). We had 
      in 11 patients respiratory complications (12%; 3 bronchopleural fistulas, 3 
      pneumonias, 3 pneumothorax > 7 days, 1 empyema, 1 chronic hypoxemia), in 15 
      patients cardiac arrhythmias which were easily controlled by medication and in 2 
      general complications (1 hemiplegia, 1 transitory stupor state). The total 
      duration of hospital stay, including SICU, acute and rehabilitative cares, was 32 
      +/- 10 (3-70) days with a mean total cost of 14,722 Sfr. per case. In conclusion, 
      surgery for NSCLC can be safely performed in intermediate cares without intensive 
      care unit at low costs and with a low morbidity and mortality provided they are 
      staffed by a specialised and well trained team.
FAU - Tschopp, J M
AU  - Tschopp JM
AD  - Centre Valaisan de Pneumologie, Montana.
FAU - Brutsche, M
AU  - Brutsche M
FAU - Frey, J G
AU  - Frey JG
FAU - Tatti, B
AU  - Tatti B
FAU - Aymon, E
AU  - Aymon E
FAU - Spiliopoulos, A
AU  - Spiliopoulos A
LA  - fre
PT  - English Abstract
PT  - Journal Article
TT  - Chirurgie thoracique pour cancer du poumon non a petites cellules. Cout-benefice 
      d'une prise en charge en soins intermediaires specialises.
PL  - Switzerland
TA  - Swiss Surg Suppl
JT  - Swiss surgery. Supplement
JID - 9514311
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Carcinoma, Non-Small-Cell Lung/rehabilitation/*surgery
MH  - Cost-Benefit Analysis
MH  - Female
MH  - Humans
MH  - Intermediate Care Facilities/*economics
MH  - Length of Stay/economics
MH  - Lung Neoplasms/rehabilitation/*surgery
MH  - Male
MH  - Middle Aged
MH  - Postoperative Complications/etiology
MH  - Thoracic Surgery/*economics
EDAT- 1996/01/01 00:00
MHDA- 1996/01/01 00:01
CRDT- 1996/01/01 00:00
PHST- 1996/01/01 00:00 [pubmed]
PHST- 1996/01/01 00:01 [medline]
PHST- 1996/01/01 00:00 [entrez]
PST - ppublish
SO  - Swiss Surg Suppl. 1996;Suppl 1:46-51.